Universitätsklinikum Gießen
Giessen, Hesse, 35392, Germany
NCT Number: NCT03753841
Dysphagia is associated with high rates of mortality and morbidity. Adjusting the oral diet of ICU-patients based on flexible endoscopic evaluation of swallowing (FEES) findings might reduce pneumonia rate, mortality and need for intubation/tracheotomy.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Giessen, Hesse, 35392, Germany
Dysphagia, a common complication in neurological disorders, leads to high rates of mortality and morbidity. It is prevalent in critically ill patients, especially those who need mechanical ventilation. The investigators therefore investigate the effect of adjusting the oral diet of our intensive care unit (ICU) patients based on flexible endoscopic evaluation of swallowing (FEES) findings, thereby assessing the impact of FEES on a neurological ICU. All patients treated on the investigators neurological ICU will be eligible for this study.
The investigators will correlate findings with baseline data, disability status, pneumonia and duration of hospitalisation, as well as a need for mechanical ventilation or a tracheotomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adjustment of oral diet based on findings in fiberendoscopic evaluation of swallowing (FEES)
Time frame: Up to 130 days
self-explanatory
Time frame: Up to 130 days
self-explanatory
Time frame: Up to 130 days
self-explanatory
Time frame: Up to 130 days
Rate of Intubation/Tracheotomy
University of Giessen
Other
Flexible Endoscopic Evaluation of Swallowing (FEES) to Determine Neurological Patients' Oral Diet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07726667
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Gaziantep, Gaz, Turkey (Türkiye)
View Trial DetailsNCT04779710
Acute Stroke, Brain Diseases
Sheffield, United Kingdom
View Trial DetailsNCT04369092
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT03672552
Brain Diseases, Central Nervous System Diseases
St. John's, Newfoundland and Labrador, Canada
View Trial Details